Digestives & Intestinal Remedies - LATAM
LATAM- In LATAM, the Digestives & Intestinal Remedies market market generated a revenue of US$2.08bn in 2024.
- It is projected to experience an annual growth rate of 3.36% (CAGR 2024-2028).
- Comparatively, China leads the global market with a revenue of US$4.41bn in 2024.
- When considering the population, the per person revenue in LATAM amounted to US$3.28 in 2024.
- In LATAM, there is a growing demand for natural and herbal digestive remedies as consumers prioritize holistic approaches to healthcare.
- Key regions:
- Canada,
- United States,
- Australia,
- Brazil,
- Japan
Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
In-Scope
- Natural and synthetic agents
- Digestive medicines
- Remedies against gastrointestinal complaints
Out-Of-Scope
- Prescription medicines
- Homeopathic remedies
- Tea
